0 seconds of 2 minutes, 9 secondsVolume 0%
Press shift question mark to access a list of keyboard shortcuts
00:00
02:09
02:09
 
  • SQI Diagnostics (SQD) reported its financial and operational results for the second quarter of fiscal 2022
  • Highlights include record sales of $5.6M in Q2 2022, compared to $0.3M in Q2 2021
  • Gross profit was $3.0M in Q2 2022, compared to $0.3M in Q2 2021
  • SQI CEO Andrew Morris sat down with Coreena Robertson to discuss the results
  • SQI Diagnostics Inc is a Canada-based company engaged in developing and commercializing technologies & products for multiplexing diagnostics
  • SQI Diagnostics opened trading at C$0.17

SQI Diagnostics (SQD) reported its financial and operational results for the first quarter of the fiscal year ending September 30, 2022.

Financial highlights include record sales of $5.6M for Q2 and gross profit of $3.0M.

SQI Diagnostics CEO Andrew Morris sat down with Coreena Robertson to discuss the news.

“We’re extremely pleased with our revenue growth this quarter, which we see as a validation of our decision to grow our business through acquisition and new product lines.

As we move forward, we hope to see continued growth fueled by our core lung health products like our RALI-Dx™ IL-6 Severity Triage Test, Exact COVID19 Antibody test and our TOR-Dx Lung products.”

SQI Diagnostics is a Canada-based company engaged in developing and commercializing technologies & products for multiplexing diagnostics.

SQI Diagnostics Inc. (SQD) opened trading at C$0.17.

Latest News
More V.SQD news on Stockhouse »
Latest Bullboard Posts
  • Cumberland
    https://ceo.ca/insiders-dashboard?insider=Cumberland+Private+Wealth+Management+Inc.Cumberland https://ceo.ca/insiders-dashboard?insider=Cumberland+Private+Wealth+Management+Inc.
    February 19, 2025
More bullboard posts for V.SQD on Stockhouse »
More From The Market Online
stock image generated with AI

@ the Bell: TSX ends March on a high note

Supported by consumer staples issues, Canada’s main stock index rose on Monday as the energy market powered growth on the TSX.

Lawyers focus on Bausch + Lomb recall investigation

Bronstein, Gewirtz & Grossman, is currently investigating potential claims on behalf of purchasers of Bausch + Lomb (NYSE:BLCO) securities.
ai generated stock image

@ the Bell: TSX sinks as investors grapple with new tariff threats

The TSX sunk on Friday in a mostly broad decline as investors avoided major bets in the face of potential new tariffs.
Gold bars under magnifying glass

A gold market snapshot as of February 2025

Gold is in the midst of a more than 120-per-cent run-up that epitomizes its investment case in 2025 and over your investment lifetime.